Letter to the Editor Re: Impact of Cost-Benefit Analysis on the Selection of Therapeutic Drugs for Patients with Overactive Bladder

• Xiuyan Tan ^[2] ; Ying Wang ^[1] ; Shuzhen Cai ^[2] ; Chunquan Song ^[3]
  1. [1] Qingdao Municipal Hospital

     Qingdao Municipal Hospital

     China

     
  2. [2] Pharmacy Department, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), 266000 Qingdao, Shandong, China
  3. [3] Pharmacy Intravenous Admixture Services, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), 266000 Qingdao, Shandong, China

  Mostrar afiliaciones +
• Localización: Archivos españoles de urología, ISSN 0004-0614, Tomo 78, Nº. 1, 2025, págs. 113-114
• Idioma: español
• Enlaces
  • Texto completo